About Calico
Calico (California Life Company) is Alphabet's biotech subsidiary founded in 2013, dedicated to understanding aging and developing interventions to extend healthy human lifespan. The company conducts fundamental research into the biology of aging and age-related diseases. Led by prominent scientists and backed by Google's resources, Calico has partnerships with pharmaceutical companies and academic institutions. The company operates with a long-term research horizon and focuses on translating basic aging research into therapeutic interventions.
Frequently Asked Questions
What does Calico do?
Alphabet's research and development biotech company focused on aging and longevity research.
How much funding has Calico raised?
Calico has raised $2.5B in total funding. The company operates in the Biotech sector.
When was Calico founded?
Calico was founded in 2013 and is headquartered in San Francisco, California.
What sector is Calico in?
Calico operates in the Biotech sector. Alphabet's research and development biotech company focused on aging and longevity research.
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Company Details
- Sector
- Biotech
- Headquarters
- San Francisco, California
- Founded
- 2013
- Status
- Active
- Total Funding
- $2.5B
